Labaran Waya

Marasa lafiya na Melanoma na iya guje wa tiyata da rikice-rikicen da ba dole ba

Written by edita

A yau, SkylineDx sun sanar da cewa gwajin su na Merlin na marasa lafiya na melanoma sun sami damar rage sama da 59% na rikice-rikice masu alaƙa da tiyata ta hanyar zaɓen marasa lafiya don tiyata. Gwajin Merlin da ke samuwa a kasuwa yana gano majinyata melanoma waɗanda za su iya aminta da barin tiyatar ƙwayar ƙwayar cuta ta sentinel lymph node biopsy (SLNB), hanyar da ake amfani da ita don tantance yaɗuwar ƙwayar cutar kansa don dalilai na tantancewa. A cikin kusan kashi 80% na marasa lafiya biopsy yana dawowa mara kyau don metastasis don haka ana iya kauce masa. Merlin yana magance mahimman buƙatu na asibiti ta hanyar gano waɗannan marasa lafiya tare da ƙarancin haɗarin metastasis a cikin ganewar asali kuma saboda haka ba zai iya rage kawai tiyatar da ba dole ba amma har ma da rikitarwa. An buga sakamakon a cikin mujallar da aka yi bitar takwarorinsu da kimiyance, The International Journal of Dermatology.

Marubutan sun binciki adadin matsalolin da ke tattare da hanyar SLNB. Don jimlar marasa lafiya 558, an bincika bayanan likitancin lantarki don tantance matsalolin da suka shafi tiyata. Bayanan su ya nuna cewa matsalolin da ke da alaƙa da SLNB sun zama ruwan dare gama gari kamar yadda 17.4% ya haɓaka aƙalla rikitarwa. Mafi yawan rikice-rikice sun hada da seroma (9.3%), kamuwa da cuta/cellulitis (4.8%) da lymphedema (4.3%). Haka kuma, majinyata shida (1.1%) sun nemi taimako a sashen gaggawa na asibitin cikin kwanaki 30 da aka yi wa tiyata, sannan an mayar da marasa lafiya tara (1.6%) zuwa asibiti a cikin kwanaki 30 na tiyatar. Daga cikin marasa lafiya 558, 279 (51%) sun sami sakamakon Jarrabawar Ƙarƙashin Haɗari. Rashin yin tiyatar SLNB a cikin waɗannan marasa lafiya 279 zai rage rikice-rikice da 59.2%, a cikin wannan rukunin.

Babu alamun wannan post.

Game da marubucin

edita

Edita a shugaba na eTurboNew ita ce Linda Hohnholz. Ta dogara ne a HQ eTN a Honolulu, Hawaii.

Leave a Comment

Share zuwa...